KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Depreciation and Depletion (2021 - 2025)

LifeMD (LFMD) has disclosed Depreciation and Depletion for 9 consecutive years, with $256431.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion rose 77.7% year-over-year to $256431.0, compared with a TTM value of $866000.0 through Dec 2025, up 85.84%, and an annual FY2025 reading of $866000.0, up 85.84% over the prior year.
  • Depreciation and Depletion was $256431.0 for Q4 2025 at LifeMD, down from $262747.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $262747.0 in Q3 2025 and bottomed at $10695.0 in Q4 2021.
  • Average Depreciation and Depletion over 5 years is $100501.9, with a median of $57666.0 recorded in 2023.
  • The sharpest move saw Depreciation and Depletion surged 319.61% in 2022, then rose 13.92% in 2023.
  • Year by year, Depreciation and Depletion stood at $10695.0 in 2021, then surged by 319.61% to $44877.0 in 2022, then increased by 28.5% to $57666.0 in 2023, then skyrocketed by 150.24% to $144302.0 in 2024, then soared by 77.7% to $256431.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for LFMD at $256431.0 in Q4 2025, $262747.0 in Q3 2025, and $184256.0 in Q2 2025.